ARTICLE | Product Development
Rescuing stroke drug development: How NIH is leading the charge
The first graduate of the institute’s preclinical stroke study is gearing up to enter its new clinical platform
November 23, 2024 2:25 AM UTC
Every 3 minutes and 14 seconds, someone dies of stroke in the U.S., yet drug developers largely abandoned the indication years ago.
A string of clinical trial failures contributed to the retreat, which has led industry to virtually ignore the second-leading cause of death worldwide. It’s a massive unmet need that should be a major market opportunity. Factors behind the failures ranged from biological unknowns to poor preclinical animal models to the difficulties of executing human stroke trials...
BCIQ Company Profiles
BCIQ Target Profiles